<!doctype html><html lang=en><head><meta name=generator content="Hugo 0.79.0"><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta property="og:title" content="Genetic testing firm 23andMe is going public via a SPAC backed by Richard Branson"><meta name=author content="The Verge"><meta name=keywords content="The-Verge"><meta property="og:title" content="Genetic testing firm 23andMe is going public via a SPAC backed by Richard Branson"><meta property="og:description" content="Photo by Smith Collection/Gado/Getty Images  Home DNA-testing company 23andMe will go public via special purpose acquisition company (SPAC) backed by Virgin Group founder Richard Branson, the companies announced Thursday. “We have always believed that healthcare needs to be driven by the consumer, and we have a huge opportunity to help personalize the entire experience at scale, allowing individuals to be more proactive about their health and wellness,” 23andMe CEO and co-founder Anne Wojcicki said in a statement."><meta property="og:type" content="article"><meta property="og:url" content="https://news.panz3r.dev/post/97a1c6692bf63d789f92f623233455aa8583b8c9552e6f2744acb0352f3849f6/"><meta property="article:published_time" content="2021-02-04T21:01:13+00:00"><meta property="article:modified_time" content="2021-02-04T21:01:13+00:00"><meta name=twitter:card content="summary"><meta name=twitter:title content="Genetic testing firm 23andMe is going public via a SPAC backed by Richard Branson"><meta name=twitter:description content="Photo by Smith Collection/Gado/Getty Images  Home DNA-testing company 23andMe will go public via special purpose acquisition company (SPAC) backed by Virgin Group founder Richard Branson, the companies announced Thursday. “We have always believed that healthcare needs to be driven by the consumer, and we have a huge opportunity to help personalize the entire experience at scale, allowing individuals to be more proactive about their health and wellness,” 23andMe CEO and co-founder Anne Wojcicki said in a statement."><link rel="shortcut icon" href=/favicon.ico><link rel=apple-touch-icon sizes=180x180 href=/apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=/favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=/favicon-16x16.png><link rel=mask-icon color=#8a0000 href=/safari-pinned-tab.svg><meta name=msapplication-TileColor content="#8A0000"><link rel=stylesheet type=text/css media=screen href=/css/normalize.min.15dd2454cf02be612cd84be5a0307ecae7e9c84d08f88ab2d1e9332717d10fe9b63484bb4c5352072da0915d1a6d48fa41994fb99c120c891cca431b4448f44d.css integrity="sha512-Fd0kVM8CvmEs2EvloDB+yufpyE0I+Iqy0ekzJxfRD+m2NIS7TFNSBy2gkV0abUj6QZlPuZwSDIkcykMbREj0TQ=="><link rel=stylesheet type=text/css media=screen href=/css/main.min.213824d03b199f0409b76c8566e3f3e4fbbe8f03c184b43a665128ee2120bbf3704a1d62249e92ad27ba4c158e21f02299e52148b06efa51a5e54824bfdf6f95.css integrity="sha512-ITgk0DsZnwQJt2yFZuPz5Pu+jwPBhLQ6ZlEo7iEgu/NwSh1iJJ6SrSe6TBWOIfAimeUhSLBu+lGl5Ugkv99vlQ=="><link rel=stylesheet type=text/css media=screen href=/css/all.min.110b9b90a76992e589133569a74d7933787d3b97d05cb148bac6c44edaa09afb226b6bd200c52f9efbe30eaecffc11b244d8ed8109b46bb490cd09109656509c.css integrity="sha512-EQubkKdpkuWJEzVpp015M3h9O5fQXLFIusbETtqgmvsia2vSAMUvnvvjDq7P/BGyRNjtgQm0a7SQzQkQllZQnA=="><title>Genetic testing firm 23andMe is going public via a SPAC backed by Richard Branson | Panz3r News</title></head><body><header><div id=titletext><h2 id=title><a href=https://news.panz3r.dev/>Panz3r News</a></h2></div><div id=title-description><div id=social><nav><ul><li><a href=https://github.com/panz3r/news-feed><i title=Github class="icons fab fa-github"></i></a></li><li><a href=/index.xml><i title=RSS class="icons fas fa-rss"></i></a></li></ul></nav></div></div><div id=mainmenu><nav><ul><li><a href=/>Home</a></li><li><a href=/tags>Tags</a></li></ul></nav></div></header><main><div class=post><div class=author><p>From <a href=https://www.theverge.com/2021/2/4/22266661/genetic-health-23andme-public-spac-richard-branson target=_blank rel="noopener noreferrer">The Verge</a></p></div><div class=post-header><div class=meta><div class=date><span class=day>04</span>
<span class=rest>Feb 2021</span></div></div><div class=matter><h1 class=title>Genetic testing firm 23andMe is going public via a SPAC backed by Richard Branson</h1></div></div><div class=markdown><figure><img alt=23Andme src="https://cdn.vox-cdn.com/thumbor/ezYSxCHWCkkCY44Iw04hXsefZ2M=/0x0:6000x4000/1310x873/cdn.vox-cdn.com/uploads/chorus_image/image/68770758/1061811696.0.jpg"><figcaption>Photo by Smith Collection/Gado/Getty Images</figcaption></figure><p id=IcdhJO>Home DNA-testing company 23andMe will go public via special purpose acquisition company (SPAC) backed by Virgin Group founder Richard Branson, the <a href=https://vgacquisition.com/>companies announced Thursday</a>.</p><p id=Is5UCY>“We have always believed that healthcare needs to be driven by the consumer, and we have a huge opportunity to help personalize the entire experience at scale, allowing individuals to be more proactive about their health and wellness,” 23andMe CEO and co-founder Anne Wojcicki said in a statement.</p><p id=ScKPc8>The deal values the company at $3.5 billion, and current shareholders will own 81 percent of the company. Wojcicki and Branson each invested $25 million themselves as part of the $250 million fund formed to take the company public. The deal is expected to close in the...</p><p><a href=https://www.theverge.com/2021/2/4/22266661/genetic-health-23andme-public-spac-richard-branson>Continue reading…</a></p></div><div class=tags><div class=taxosfloating_left><p>Tags</p></div><div class=termsfloating_right><p><a href=/tags/the-verge/>the-verge</a></p></div><div class=clearit></div></div></div></main><footer><a href=https://github.com/panz3r>Panz3r</a> 2020 | <a href=https://github.com/panz3r/hugo-vitae>Vitae</a> theme for <a href=https://gohugo.io>Hugo</a></footer></body></html>